On 28 February 2020, orphan designation EU/3/20/2249 was granted by the European Commission to SparingVision, France, for adeno-associated virus serotype 8 containing the human RdCVF sequence and the human RdCVFL sequence (also known as SPVN06) for the treatment of inherited retinal dystrophies.
EU/3/20/2249: Public summary of positive opinion for orphan designation of adeno-associated virus serotype 8 containing the human RdCVF sequence and the human RdCVFL sequence for the treatment of inherited retinal dystrophies (PDF/216.72 KB)
First published: 05/05/2020
Adeno-associated virus serotype 8 containing the human RdCVF sequence and the human RdCVFL sequence
|Disease / condition||
Treatment of inherited retinal dystrophies
|Date of first decision||
|EU designation number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.